BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

Welcsh, P. L.·2001·Human Molecular Genetics
DOI 10.1093/hmg/10.7.705

Cited by (647)

Items 101–200 of 647

  1. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers
    Camilo Adem, Carol A. Reynolds, Cheryl L. Soderberg, Jeffrey M. Slezak, Shannon K. McDonnell, Thomas J. Sebo, Daniel J. Schaid, Jeffrey L. Myers, Thomas A. Sellers, Lynn C. Hartmann et al. · 2002 · Cancer
  2. Confounding, ascertainment bias, and the blind quest for a genetic ‘fountain of youth’
    Joseph Douglas Terwilliger, Kenneth M. Weiss · 2003 · Annals of Medicine
  3. Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses
    Nan‐Shan Chang, Joan Doherty, Amy Ensign, Jennifer J. Lewis, John Heath, Lori Schultz, Shur-Tzu Chen, Udo C. T. Oppermann · 2003 · Biochemical Pharmacology
  4. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2
    Kathleen Claes, Bruce Graham Poppe, Eva Macháčková, Ilse Coene, Lenka Foretová, Anne De Paepe, Ludwine M. Messiaen · 2003 · Genes Chromosomes and Cancer
  5. BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management
    Michelle V. Lee, Venkata Subbiah Katabathina, Michyla Bowerson, Marina I. Mityul, Anup S. Shetty, Khaled M. Elsayes, Aparna Balachandran, Priya Bhosale, Ann E. McCullough, Christine O. Menias · 2017 · Radiographics
  6. UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas
    Maria Teresa Berlingieri, Pierlorenzo Pallante, Marco Guida, Carmine Nappi, Valeria Masciullo, Giovanni Scambia, Angelo Ferraro, Vincenza Leone, Andrea Sboner, Mattia Barbareschi et al. · 2006 · Oncogene
  7. Haplo-insufficiency of BRCA1 in sporadic breast cancer.
    Synnöve M. Staff, Jorma J Isola, Minna Tanner · 2003 · PubMed
  8. Good Timing in the Cell Cycle for Precise DNA Repair by BRCA1
    Stephen T. Durant, Jac A. Nickoloff · 2005 · Cell Cycle
  9. Parathyroid carcinoma
    Elizabeth Ann Mittendorf, Christopher R. McHenry · 2005 · Journal of Surgical Oncology
  10. Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma
    Trisha M. Shattuck, Teresa S. Kim, Jessica L. Costa, David W. Yandell, Yasuo Imanishi, Nallasivam Palanisamy, Randall D. Gaz, Dolores Shoback, Orlo H. Clark, John M. Monchik et al. · 2003 · Clinical Endocrinology
  11. Evaluation of Rucaparib and Companion Diagnostics in the PARP Inhibitor Landscape for Recurrent Ovarian Cancer Therapy
    Zachary B. Jenner, Anil K. Sood, Robert L. Coleman · 2016 · Future Oncology
  12. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study
    the NICER Working Group, Anita Feller, Katarina Luise Matthes, Andrea Bordoni, Christine Bouchardy, Jean‐Luc Bulliard, C. Herrmann, Isabelle Konzelmann, Manuela Maspoli, Seyed Mohsen Mousavi et al. · 2020 · BMC Cancer
  13. UbcH10 is overexpressed in malignant breast carcinomas
    Maria Teresa Berlingieri, Pierlorenzo Pallante, Andrea Sboner, Mattia Barbareschi, Mimma Bianco, Angelo Ferraro, Gelsomina Mansueto, Eleonora Borbone, Eliana Guerriero, Giancarlo Troncone et al. · 2007 · European Journal of Cancer
  14. em BRCA1 em in cancer cell cycle and genomic stability
    Meena Jhanwar‐Uniyal · 2003 · Frontiers in bioscience
  15. Counseling for male BRCA mutation carriers: a review.
    Hussain Mohamad, J. Apffelstaedt · 2008 · Breast
  16. Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations
    Ainhoa Madariaga, Stéphanie Lheureux, Amit M. Oza · 2019 · Cancers
  17. Network biomarkers reveal dysfunctional gene regulations during disease progression
    Tao Zeng, Shao‐yan Sun, Yong Wang, Hailong Zhu, Luonan Chen · 2013 · FEBS Journal
  18. A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example
    Leila Mohammadi, Maaike P.G. Vreeswijk, Rogier A. Oldenburg, Ans van den Ouweland, Jan C. Oosterwijk, Annemarie H. van der Hout, Nicoline Hoogerbrugge, Marjolijn J. L. Ligtenberg, Margreet G.E.M. Ausems, Rob B. van der Luijt et al. · 2009 · BMC Cancer
  19. Racial differences in genetic factors associated with breast cancer
    Foluso Olabisi Ademuyiwa, Olufunmilayo Ibironke Olopade · 2003 · Cancer and Metastasis Reviews
  20. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis
    Krishna Kumar Singh, Praphulla Chandra Shukla, Adrian Quan, Mohammed A. Al-Omran, Fina Lovren, Yi Pan, Christine Brezden‐Masley, Alistair John Ingram, William L. Stanford, Hwee Teoh et al. · 2013 · Journal of Thoracic and Cardiovascular Surgery
  21. BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management
    Giulia Girolimetti, Anna Myriam Perrone, Donatella Santini, Elena Barbieri, Flora Guerra, Simona Ferrari, Claudio Zamagni, Pierandrea De Iaco, Giuseppe Gasparre, Daniela Turchetti · 2014 · BioMed Research International
  22. Dysregulation of ubiquitin ligases in cancer
    Jianfei Qi, Ze’ev A. Ronai · 2015 · Drug Resistance Updates
  23. Identification of HLA‐A3‐restricted CD8+ T cell epitopes derived from mammaglobin‐A, a tumor‐associated antigen of human breast cancer
    Andrés Jaramillo, Kanchana Majumder, Partha Pratim Manna, Timothy P. Fleming, Gerard M. Doherty, John F. DiPersio, Thalachallour Mohanakumar · 2002 · International Journal of Cancer
  24. Sporadic Epithelial Ovarian Cancer: Clinical Relevance of BRCA1 Inhibition in the DNA Damage and Repair Pathway
    Johanne Ingrid Weberpals, Katherine V. Clark-Knowles, Barbara C. Vanderhyden · 2008 · Journal of Clinical Oncology
  25. Ovarian surface epithelium: family history and early events in ovarian cancer
    Alice S.T. Wong, Nelly Auersperg · 2003 · Reproductive Biology and Endocrinology
  26. Mouse Mammary Tumor Biology: A Short History
    Robert D. Cardiff, Nicholas J. Kenney · 2007 · Advances in cancer research
  27. The Epidemiology of Pesticide Exposure and Cancer: A Review
    Kushik Jaga, Chandrabhan Dharmani · 2005 · Reviews on Environmental Health
  28. Repetitive sequences that shape the human transcriptome
    Anna J. Jasinska, Włodzimierz J. Krzyżosiak · 2004 · FEBS Letters
  29. Germline testing and genetic counselling in prostate cancer
    Jessica R. Russo, Veda N. Giri · 2022 · Nature Reviews Urology
  30. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977–2001
    Michael Andersson, Maj‐Britt Jensen, Gerda Engholm, Hans Henrik Storm · 2008 · Acta Oncologica
  31. YAP Regulates S-Phase Entry in Endothelial Cells
    Zhewei Shen, Ben Z. Stanger · 2015 · PLoS ONE
  32. The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies
    Kalen J. Rimar, Phuoc Tho Tran, Richard S. Matulewicz, Maha Hussain, Joshua J. Meeks · 2017 · Cancer
  33. Identification of novel loci associated with maturity and yield traits in early maturity soybean plant introduction lines
    Tanya Rose Copley, Marc‐Olivier Duceppe, Louise S. O’Donoughue · 2018 · BMC Genomics
  34. Degradation of 5hmC-marked stalled replication forks by APE1 causes genomic instability
    Suhas S. Kharat, Xia Ding, Divya Swaminathan, Akshey Suresh, Manish P. Singh, Satheesh Kumar Sengodan, Sandra Sczerba Burkett, Hanna Marks, Chinmayi Pamala, Yafeng He et al. · 2020 · Science Signaling
  35. Mechanisms of X Chromosome Dosage Compensation
    Sevinç Ercan · 2014 · Journal of Genomics
  36. Genomic instability in histologically normal breast tissues: implications for carcinogenesis
    Darrell L. Ellsworth, Rachel E. Ellsworth, Michael Liebman, Jeffrey A. Hooke, Craig D. Shriver · 2004 · The Lancet Oncology
  37. Large genomic deletions inactivate the BRCA2 gene in breast cancer families
    Simona Agata, M Dalla Palma, M Callegaro, M C Scaini, C Menin, C Ghiotto, O Nicoletto, G Zavagno, L Chieco-Bianchi, E D’Andrea et al. · 2005 · Journal of Medical Genetics
  38. Characterization of potential driver mutations involved in human breast cancer by computational approaches
    Rajendran, Barani Kumar, Deng, Chu-Xia · 2017 · Oncotarget
  39. A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing
    Gillian Ellison, Shuwen Huang, Thomas Hedley Carr, Andrew J. Wallace, Miika J. Ahdesmaki, Sanjeev S. Bhaskar, JOHN S. MILLS · 2015 · BMC Clinical Pathology
  40. Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors
    H. Johannsdottir, Goran B Jönsson, Guðrún Jóhannesdóttir, Bjarni Agnar Agnarsson, Hannaleena Eerola, Aðalgeir Arason, Päivi Heikkilä, Valgarður Egilsson, Hakan Lars Olsson, Oskar T. Johannsson et al. · 2006 · International Journal of Cancer
  41. The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway
    Virginia De Cesare, Clare Johnson, Victoria L. Barlow, C. James Hastie, Axel Knebel, Matthias Trost · 2018 · Cell chemical biology
  42. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women
    The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk · 2009 · Breast Cancer Research and Treatment
  43. Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Breast Cancer Risk
    Angela M. González‐Zuloeta Ladd, Alejandro Arias Vásquez, Fakhredin A. Sayed‐Tabatabaei, J.W.W. Coebergh, Albert Hofman D, Omer Tchikamgoua Njajou, Bruno H. Ch. Stricker, Cornelia M. van Duijn · 2005 · Cancer Epidemiology Biomarkers & Prevention
  44. BRCA1: the enigma of tissue-specific tumor development.
    A. Monteiro · 2003 · Trends in Genetics
  45. Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next‐generation sequencing
    Yosuke Hirotsu, Hiroshi Nakagomi, Ikuko Sakamoto, Kenji Amemiya, Hitoshi Mochizuki, Masao Omata · 2014 · Molecular Genetics & Genomic Medicine
  46. PD-1/PD-L1 expression in pancreatic cancer and its implication in novel therapies
    Adrian Mucileanu, Romeo Ioan Chira, Petru Adrian Mircea · 2021 · Medicine and Pharmacy Reports
  47. Brca1 regulates in vitro differentiation of mammary epithelial cells
    Marion Kubista, Margit Rosner, Ernst Kubista, GERHARD BERNASCHEK, Markus Hengstschläger · 2002 · Oncogene
  48. The ?portrait? of hereditary breast cancer
    Marc Lacroix, Guy Leclercq · 2005 · Breast Cancer Research and Treatment
  49. Anchoring the genome
    Diego Ottaviani, Elliott Lever, Petros Takousis, Denise Sheer · 2008 · Genome biology
  50. Personalized Medicine is More Than Genomic Medicine: Confusion Over Terminology Impedes Progress Towards Personalized Healthcare
    Leigh Ann Simmons, Michaela Ann Dinan, Timothy J. Robinson, Ralph Snyderman M. D · 2011 · Personalized Medicine
  51. Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women
    Mónica P. Cala, Julian Aldana, Jessica M. Medina, Julián Sánchez Castillo, José Ismael Guío Ávila, Julien Wist, Roland J. W. Meesters · 2018 · PLoS ONE
  52. JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction
    Yan-Fen Hu, Rong Li · 2002 · Genes & Development
  53. BRCA2 Protein Deficiency Exaggerates Doxorubicin-induced Cardiomyocyte Apoptosis and Cardiac Failure
    Krishna Kumar Singh, Praphulla Chandra Shukla, Adrian Quan, Jean‐François Desjardins, Fina Lovren, Yi Pan, Vinay Garg, Sumandeep Gosal, Ankit Garg, Paul E. Szmitko et al. · 2011 · Journal of Biological Chemistry
  54. The Genetics of Cancer Risk
    Mark M. Pomerantz, Matthew L. Freedman · 2011 · The Cancer Journal
  55. Targeting Signaling Pathways in Epithelial Ovarian Cancer
    Elisabeth Smolle, Valentin Taucher, Martin Pichler, Edgar Petru, Sigurd Lax, Johannes Haybaeck · 2013 · International Journal of Molecular Sciences
  56. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis
    Bonnie H. Y. Yeung, Bernadette W.Y. Kwan, Qing‐Yu He, Amy Shiu Lee, Jinsong Liu, Alice S.T. Wong · 2008 · Oncogene
  57. Heterogeneity of breast cancer: etiology and clinical relevance
    Vanessa Almendro, Gemma Fuster · 2011 · Clinical & Translational Oncology
  58. Breast cancer susceptibility testing: past, present and future
    Jessica Goldberg, Patrick Ivan Borgen · 2006 · Expert Review of Anticancer Therapy
  59. Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients
    Yeong C. Kim, Linli Zhao, Hanwen Zhang, Ye Huang, Jian Cui, Fengxia Xiao, Bradley M. Downs, San Ming Wang · 2016 · Oncotarget
  60. TGFBR1 Signaling and Breast Cancer
    Lakisha D. Moore-Smith, Boris Pasche · 2011 · Journal of Mammary Gland Biology and Neoplasia
  61. Advances in Prostate Cancer Biomarkers and Probes
    Keyi Li, Qiao Wang, Xiaoying Tang, Ozioma Udochukwu Akakuru, Ruobing Li, Yan Wang, Renran Zhang, Zhenqi Jiang, Zhuo Yang · 2024 · Cyborg and Bionic Systems
  62. Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics
    Jin‐Xue He, Chunhao Yang, Ze‐Hong Miao · 2010 · Acta Pharmacologica Sinica
  63. A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2genes based on cancer family history
    Encarna B. Gómez-García, Jan C. Oosterwijk, M. M. M. S. Timmermans, Christie J. van Asperen, Frans B.L. Hogervorst, Nicoline Hoogerbrugge, Rogier A. Oldenburg, Senno Verhoef, Charlotte J. Dommering, Margreet G.E.M. Ausems et al. · 2009 · Breast Cancer Research
  64. Tumoral expression of BRCA1, Estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer
    Gloria B. Roldán, Lucia Beatriz Delgado, Ignacio Musé · 2006 · Cancer Biology & Therapy
  65. Risk of second primary cancer among women with breast cancer: A population-based study in Granada (Spain)
    Esther Molina‐Montes, Marina Pollán, Tilman Payer, Elena Molina‐Portillo, Cristina Dávila-Arias, María‐José Sánchez · 2013 · Gynecologic Oncology
  66. Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
    Haller J. Smith, John Michael Straughn, Donald J. Buchsbaum, Rebecca Christian Arend · 2017 · Gynecologic Oncology Reports
  67. The Icelandic founder mutation BRCA2 999del5: analysis of expression
    Evgenia Mikaelsdottir, Sigrı́dur Valgeirsdóttir, Jorunn Erla Eyfjord, Þórunn Rafnar · 2004 · Breast Cancer Research
  68. Alkaline single-cell gel electrophoresis (comet assay)
    S. Colleu-Durel, Nathalie Guitton, K. Nourgalieva, Florence Legué, Jean Lévêque, Bruno Danic, C Chenal · 2003 · European Journal of Cancer
  69. EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases
    Isabelle Cousineau, Abdellah Belmaaza · 2011 · Molecular Genetics and Genomics
  70. PARP Inhibitors in Reproductive System Cancers: Current Use and Developments
    Geraldine O’Sullivan Coyne, Alice P. Chen, Robert S. Meehan, James H. Doroshow · 2017 · Drugs
  71. BRCA1 foci in normal S-phase nuclei are linked to interphase centromeres and replication of pericentric heterochromatin
    Gayle J. Pageau, Jeanne Bentley Lawrence · 2006 · The Journal of Cell Biology
  72. Rapid Microwave-Assisted Cisplatin-Loaded Solid Lipid Nanoparticles: Synthesis, Characterization and Anticancer Study
    Hibah Mubarak Aldawsari, Sima Singh · 2020 · Nanomaterials
  73. Fenretinide: a prototype cancer prevention drug
    Winfred F. Malone, Marjorie Perloff, James A. Crowell, Caroline C. Sigman, Howard R. Higley · 2003 · Expert Opinion on Investigational Drugs
  74. PARP inhibitor receives FDA breakthrough therapy designation in castration resistant prostate cancer: beyond germline BRCA mutations
    Thomas Helleday · 2016 · Annals of Oncology
  75. Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan
    Tsai-Wang Chang, Shuei-Ming Wang, Yue Leon Guo, Pei‐Chien Tsai, Chien-Jung Huang, Wenya Huang · 2006 · The Breast
  76. Incidence of second primary malignancy after breast cancer and related risk factors—Is breast‐conserving surgery safe? A nested case–control study
    Zhuyue Li, Kang Wang, Yang Shi, Xuemei Zhang, Jin Wen · 2019 · International Journal of Cancer
  77. High-level transgene expression by homologous recombination-mediated gene transfer
    Grandjean, Mélanie, Girod, Pierre-Alain, Calabrese, David, Kostyrko, Kaja, Wicht, Marianne, Yerly, Florence, Mazza, Christian, Beckmann, Jacques S., Martinet, Danielle, Mermod, Nicolas · 2011 · Nucleic Acids Research
  78. A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women
    Zhanwei Wang, Yan Xu, Jinhai Tang, Hongxia Ma, Jianwei Qin, Lu Chen, Xuechen Wang, Zhibin Hu, Xinru Wang, Hongbing Shen · 2009 · Breast Cancer Research and Treatment
  79. Assembly of an Evolutionarily Conserved Alternative Proteasome Isoform in Human Cells
    Achuth Padmanabhan, Simone Anh-Thu Vuong, Mark Hochstrasser · 2016 · Cell Reports
  80. Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families
    Sophie Gad, M Klinger, Virginie Caux‐Moncoutier, S Pages-Berhouet, Marion Gauthier‐Villars, I Coupier, A Bensimon, Alain Aurias, Dominique Stoppa‐Lyonnet · 2002 · Journal of Medical Genetics
  81. Ovarian Carcinomas in Endometriosis: An Immunohistochemical and Comparative Genomic Hybridization Study
    Paulette Mhawech, Karen Kinkel, Georges Vlastos, Marie‐Françoise Pelte · 2002 · International Journal of Gynecological Pathology
  82. Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin
    Wei-Ching Chen, Hui‐Ping Hsu, Chung-Yen Li, Ya‐Ju Yang, Yu-Hsuan Hung, Chien-Yu Cho, Chih‐Yang Wang, Tzu‐Yang Weng, Ming-Derg Lai · 2016 · International Journal of Oncology
  83. Challenges for Super-Resolution Localization Microscopy and Biomolecular Fluorescent Nano-Probing in Cancer Research
    Michael Hausmann, Nataša Ilić, Götz Pilarczyk, Jinho Lee, Abiramy Logeswaran, Aurora Paola Borroni, Matthias Krufczik, Franziska Theda, Nadine Waltrich, Felix Bestvater et al. · 2017 · International Journal of Molecular Sciences
  84. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
    Chun‐Ming Wong, Joyce Man Fong Lee, Tracy C.M. Lau, Sheung Tat Fan, Irene Oi‐Lin Ng · 2002 · PubMed
  85. Molecular and in silico analysis of BRCA1 and BRCA2 variants
    Stefania Tommasi, Brunella Pilato, Rosamaria Pinto, Alessandro Monaco, Michele Bruno, Marco Campana, Maria Digennaro, Francesco Schittulli, Rosanna Lacalamita, Angelo Paradiso · 2008 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  86. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer
    John Lai, James M. Flanagan, Wayne Allen Phillips, Georgia Chenevix‐Trench, Jeremy M. Arnold · 2003 · British Journal of Cancer
  87. BeWith: A Between-Within method to discover relationships between cancer modules via integrated analysis of mutual exclusivity, co-occurrence and functional interactions
    Phuong Dao, Yoo-Ah Kim, Damian Wójtowicz, Sanna Madan, Roded Sharan, Teresa M. Przytycka · 2017 · PLoS Computational Biology
  88. SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy
    Mi Ae Park, Yeong‐Jae Seok, Gajin Jeong, Jong Soo Lee · 2007 · Nucleic Acids Research
  89. Epidemiology of breast cancer among BRCA mutation carriers: an overview
    André Nkondjock, Parviz Ghadirian · 2003 · Cancer Letters
  90. A review on genotoxicity in connection to infertility and cancer
    Sharmistha Choudhuri, Taruneet Kaur, Sapna Jain, Chandresh Sharma, Shailendra Asthana · 2021 · Chemico-Biological Interactions
  91. Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas
    Christine Walsh, Seishi Ogawa, Daniel R. Scoles, Carl W. Miller, Norihiko Kawamata, Steven Alexander Narod, Harold Phillip Koeffler, Beth Y. Karlan · 2008 · Clinical Cancer Research
  92. Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics
    C. Scott, M. Jenkins, M. Southey, T. Davis, J. Leary, D. Easton, K. Phillips, J. Hopper · 2003 · Human Genetics
  93. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
    Huang, Jau-Ling, Chang, Yu-Tzu, Hong, Zhen-Yang, Lin, Chang-Shen · 2022 · International Journal of Molecular Sciences
  94. The use of biomarkers in the military: From theory to practice
    Rachel Yehuda, Thomas C. Neylan, Janine Dyck Flory, ALEXANDER COWELL McFARLANE · 2013 · Psychoneuroendocrinology
  95. Functional Dissection of Transcription Factor ZBRK1 Reveals Zinc Fingers with Dual Roles in DNA-binding and BRCA1-dependent Transcriptional Repression
    Wei Tan, Lei Zheng, Wen‐Hwa Lee, Thomas Boyer · 2004 · Journal of Biological Chemistry
  96. Synthetic Lethality in Ovarian Cancer
    Chandrasekaran, Akshaya, Elias, Kevin M. · 2021 · Molecular Cancer Therapeutics
  97. Mutator Phenotype ofCaenorhabditis elegansDNA Damage Checkpoint Mutants
    Jasper Harris, Mia Rochelle Lowden, Iuval Clejan, Monika Tzoneva, James H. Thomas, Jonathan Hodgkin, Shawn Cameron Ahmed · 2006 · Genetics
  98. Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients
    Dana Hamam, Mohamed Abdouh, Zu‐Hua Gao, Vincenzo Arena, Manuel Arena, Goffredo Orazio Arena · 2016 · Journal of Experimental & Clinical Cancer Research
  99. BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations
    Safoora Deihimi, Avital Lev, Michael J. Slifker, Elena I. Shagisultanova, Qifang Xu, Kyungsuk Jung, Namrata Vijayvergia, Eric A. Ross, Joanne Xiu, Jeffrey J. Swensen et al. · 2017 · Oncotarget
  100. Amplification of HER2 is a marker for global genomic instability
    Rachel E. Ellsworth, Darrell L. Ellsworth, Heather L. Patney, Brenda Deyarmin, Brad Love, Jeffrey A. Hooke, Craig D. Shriver · 2008 · BMC Cancer